Atypical femoral fracture in a multiple myeloma patient undergoing treatment with denosumab: A case report and literature review

INTRODUCTION AND IMPORTANCE: Denosumab is a new standard treatment for bone disease caused by multiple myeloma. There are a few reports of atypical femoral fracture in patients with multiple myeloma, all of which were associated with long-term use of bisphosphonate. Here, we report the first case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Omichi, Yasuyuki, Toki, Shunichi, Nishisho, Toshihiko, Harada, Takeshi, Sato, Nori, Sairyo, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382856/
https://www.ncbi.nlm.nih.gov/pubmed/37421768
http://dx.doi.org/10.1016/j.ijscr.2023.108456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382856/
https://www.ncbi.nlm.nih.gov/pubmed/37421768
http://dx.doi.org/10.1016/j.ijscr.2023.108456

Ejemplares similares